UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode

Journal of affective disorders, 2020-03, Vol.264, p.318-323

2020

Volltextzugriff (PDF)

Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment

Strahlentherapie und Onkologie, 2021-12, Vol.197 (12), p.1051-1062

2021

Volltextzugriff (PDF)

Renal effects of parenteral fish oil administered to heart-beating organ donors and renal-transplant recipients: a tolerance study

Clinical nutrition (Edinburgh, Scotland), 2004-08, Vol.23 (4), p.597-603

2004

Volltextzugriff (PDF)

International uniform response criteria for multiple myeloma

Leukemia, 2006-09, Vol.20 (9), p.1467-1473

2006

Volltextzugriff (PDF)

Comparison of the analgesic effects of "superficial" and "deep" repetitive transcranial magnetic stimulation in patients with central neuropathic pain: a randomized sham-controlled multicenter international crossover study

Pain (Amsterdam), 2024-04, Vol.165 (4), p.884-892

2024

Volltextzugriff (PDF)

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

Neurology, 2004-01, Vol.62 (2), p.218-225

2004

Volltextzugriff (PDF)

A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia

Pain (Amsterdam), 2013-05, Vol.154 (5), p.761-767

2013

Volltextzugriff (PDF)

Repetitive transcranial magnetic stimulation and transcranial direct-current stimulation in neuropathic pain due to radiculopathy: a randomized sham-controlled comparative study

Pain (Amsterdam), 2016-06, Vol.157 (6), p.1224-1231

2016

Volltextzugriff (PDF)

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

The Lancet (British edition), 2019-07, Vol.394 (10192), p.29-38

2019

Volltextzugriff (PDF)

Efficacy and safety of pre-Descemet's membrane sutures for the management of acute corneal hydrops in keratoconus

British journal of ophthalmology, 2015-06, Vol.99 (6), p.773-777

2015

Volltextzugriff (PDF)

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Haematologica (Roma), 2010-10, Vol.95 (10), p.1738-1744

2010

Volltextzugriff (PDF)

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

Leukemia, 2010-03, Vol.24 (3), p.623-628

2010

Volltextzugriff (PDF)

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

Blood, 2011-05, Vol.117 (18), p.4691-4695

2011

Volltextzugriff (PDF)

Topical clonazepam in stomatodynia: a randomised placebo-controlled study

Pain (Amsterdam), 2004-03, Vol.108 (1), p.51-57

2004

Volltextzugriff (PDF)

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (11), p.1409-1414

2013

Volltextzugriff (PDF)

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

The New England journal of medicine, 2008-08, Vol.359 (9), p.906-917

2008

Volltextzugriff (PDF)

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

The New England journal of medicine, 2010-12, Vol.363 (26), p.2511-2521

2010

Volltextzugriff (PDF)

Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study

The Clinical journal of pain, 2017-10, Vol.33 (10), p.921-931

2017

Volltextzugriff (PDF)

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

Blood, 2002-11, Vol.100 (9), p.3128-3134

2002

Volltextzugriff (PDF)

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Blood, 2002-02, Vol.99 (3), p.731

2002

Volltextzugriff (PDF)

1 – 25 von 60

Suche als RSS-Feed

Aktive Filter

ThemaTreatment Outcome

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(56)
Mit Volltextzugriff
(45)

Publikationsform

Artikel
(60)

Sprache

Englisch
(60)

Erscheinungsjahr

n.n

Thema

Humans
(60)
Life Sciences & Biomedicine
(53)
Science & Technology
(53)
Female
(45)
Male
(44)
Middle Aged
(42)
Adult
(40)
Biological And Medical Sciences
(29)
Hematology
(29)
Medical Sciences
(29)
Aged
(22)
Survival Analysis
(20)
Oncology
(18)
Adolescent
(17)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Disease-Free Survival
(15)
Retrospective Studies
(15)
Follow-Up Studies
(14)
Multiple Myeloma - Drug Therapy
(14)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Adherence to treatment guidelines in clinical practice for using electroconvulsive therapy in major depressive episode

Evaluation of two modalities of perioperative treatment in the management of extremity and truncal soft tissue sarcomas: neoadjuvant concurrent chemoradiotherapy and sequential treatment

Renal effects of parenteral fish oil administered to heart-beating organ donors and renal-transplant recipients: a tolerance study

Final analysis of survival outcomes in the phase 3 FIRST trial of up-front treatment for multiple myeloma

Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations

International uniform response criteria for multiple myeloma

Comparison of the analgesic effects of "superficial" and "deep" repetitive transcranial magnetic stimulation in patients with central neuropathic pain: a randomized sham-controlled multicenter international crossover study

Systemic lidocaine in pain due to peripheral nerve injury and predictors of response

A randomized, double-blind, placebo-controlled trial of a chemokine receptor 2 (CCR2) antagonist in posttraumatic neuralgia

Repetitive transcranial magnetic stimulation and transcranial direct-current stimulation in neuropathic pain due to radiculopathy: a randomized sham-controlled comparative study

Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study

Efficacy and safety of pre-Descemet's membrane sutures for the management of acute corneal hydrops in keratoconus

Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma

Impact of high-risk cytogenetics and prior therapy on outcomes in patients with advanced relapsed or refractory multiple myeloma treated with lenalidomide plus dexaméthasone

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

Topical clonazepam in stomatodynia: a randomised placebo-controlled study

The outcome of reduced intensity allogeneic stem cell transplantation and autologous stem cell transplantation when performed as a first transplant strategy in relapsed follicular lymphoma: an analysis from the Lymphoma Working Party of the EBMT

Bortezomib plus Melphalan and Prednisone for Initial Treatment of Multiple Myeloma

Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia

Age is a prognostic factor even among patients with multiple myeloma younger than 66 years treated with high-dose melphalan: the IFM experience on 2316 patients

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

Capsaicin 8% Patch Repeat Treatment in Nondiabetic Peripheral Neuropathic Pain: A 52-Week, Open-Label, Single-Arm, Safety Study

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy

Aktive Filter

Suchergebnisse filtern